Roche’s Susvimo, a refillable eye implant for diabetic macular edema, provides continuous delivery of ranibizumab, showing ...

Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the US Food and Drug Administration (FDA) has approved Susvimo® (ranibizumab injection) 100 mg/mL for the treatment of diabetic macular edema ...

Diabetic vitreous hemorrhage is linked to neuropathologic changes in specific brain regions, as identified by voxel-based ...

AI Optics, a biotech startup backed by NYU Langone and raising in stealth, announced clearance this week from the Food and ...

Protect your vision in 2025 with these 10 simple eye care habits, from screen breaks to a nutrient-rich diet, ensuring long-term eye health and clarity.

The World Health Organization reports that around 2.2 billion people struggle with vision problems such as near-sightedness ...

Discover the importance of vision, genetic eye disorders, and RNA-based therapies for precision treatment in India and ...

More than a million Brits could be living with undiagnosed diabetes, with early detection being key to managing the condition and maintaining a good quality of life ...

Glaucoma Treatment MarketThe global glaucoma treatment market, valued at USD 5.7 billion in 2022, is projected to grow at a ...

Researchers discovered that higher levels of “good” cholesterol (HDL), which is usually considered beneficial for heart ...

As a retina specialist, one of the most important aspects of eye care I focus on is the prevention and treatment of diabetic retinopathy. This condition is a leading cause of blindness in adults, yet ...

Genentech Inc. won regulatory approval Tuesday to market an eye implant that can be refilled every six months with an already ...